5 May 2023 in Russian Annals of Ophthalmology
Возрастная макулярная дегенерация (ВМД) — заболевание, развивающееся у лиц старшей возрастной группы, в основе патогенеза которого лежит поражение ретинального пигментного эпителия и мембраны Бруха. На сегодняшний день в мире известны восемь анти-VEGF-препаратов для лечения неоваскулярной формы ВМД (нВМД), четыре из них зарегистрированы и используются в клинической практике. Первым зарегистрированным препаратом был пегаптаниб, селективно блокирующий VEGF165. В дальнейшем появилась молекула с похожим механизмом действия: ранибизумаб представляет собой гуманизированный моноклональный Fab-фрагмент, специально разработанный для офтальмологии. Его преимущество перед пегаптанибом — в нейтрализации всех активных изоформ VEGF-A. Афлиберцепт и конберцепт — рекомбинантные гибридные белки, действующие как растворимые рецепторы-ловушки для белков семейства VEGF. Данные III фазы исследований VIEW 1 и 2 показали, что интравитреальное введение (ИВВ) афлиберцепта каждые 1 или 2 мес на протяжении года приводит к функциональным результатам, сопоставимым с таковыми после ежемесячных ИВВ ранибизумаба на протяжении года. В 2019 г. была зарегистрирована следующая молекула для анти-VEGF-терапии, показавшая эффективность, — бролуцизумаб (одноцепочечный фрагмент гуманизированного антитела). Бролуцизумаб с высокой аффинностью связывается с различными изоформами VEGF-A. Параллельно с исследованием бролуцизумаба проводилось изучение Abicipar pegol, но данный препарат не был зарегестрирован из-за высокого процента осложнений. Последним из зарегистрированных препаратов для лечения нВМД стал фарицимаб. Молекула этого препарата представляет собой гуманизированное антитело иммуноглобулина G, воздействующее на две ключевые точки ангиогенеза: VEGF-A и ангиопоэтин-2 (Ang-2). Таким образом, стратегия развития анти-VEGF-терапии заключается в создании молекул с большей эффективностью (с лучшим воздействием на новообразованные сосуды, приводящим к резорбции экссудата в сетчатке, под нейроэпителием и под ретинальным пигментным эпителием), что позволяет не только сохранить зрение, но и при отсутствии макулярной атрофии существенно его повысить.
22 October 2021 in Ophthalmology in Russia
Macular hole (MH) is one of the most common pathologies of the macular area of the retina which leads to a significant decrease in visual acuity. The article presents early comparative morphofunctional results of surgical treatment of 60 patients (22 men and 38 women) with MH of the III–IV stages according to Gass and the minimum diameter (MinD) MH 404–696 microns. All patients included in the study had pseudophakia and have not previously undergone endovitreal interventions. Patients with MH with a diameter of 404–696 μm were randomized and divided into 3 equal groups: after three-port 25G pars plana posterior vitrectomy the patients of the first group underwent peeling of the inner limited membrane (ILM) with the convergence of the edges of MH and vitreous cavity tamponade with 16 % gas-air mixture of perfluoropropane (C2F6). In the area of the macular defect, patients of the second group underwent application of autologous conditioned plasma (ACP) in the PFСs environment and the convergence of the edges of MH. In patients of the third group, MH was closed using the technique of an inverted ILM flap. In patients of groups 2 and 3 the operation was completed by tamponade of the vitreous cavity with sterile air. Standard and special research methods, such as optical coherence tomography of the macular zone, were performed before surgery, 5 days and 1 month after surgery in all patients from groups 2 and 3. Patients from group 1 were examined before surgery and 1 month after surgical treatment, due to the long-lasting gas-air mixture in the vitreous cavity. Restoration of the correct structure of the fovea with the formation of U- and V-shaped profile during OCT after 1 month was noted in all cases. The data obtained demonstrate the peculiarities of using the inverted ILM flap and ACP methods in comparison with the traditional method of MH closure with a gas-air mixture.
23 April 2024 in Russian Annals of Ophthalmology
Optical coherence tomography of the anterior segment of the eye (AS-OCT) is a non-invasive method based on the principles of optical reflectometry (measurement of the degree of backscattering of light passing through transparent or translucent media). Limitations of the first devices of this type were associated with insufficient image quality of the details of the anterior chamber angle and the posterior parts of the lens, primarily due to the “working” level of the scanning wavelength (within 800 μm). Fundamentally new possibilities in the structural and functional assessment of the anterior segment of the eye are associated with the introduction into clinical practice of swept-source AS-OCT device — the CASIA2 anterior optical coherence tomograph (Tomey Corporation, Japan). Its high scanning speed (50 000 A-scans per second) with a wavelength of 1310 μm allows high-quality visualization by building a scan at a depth of 13 mm. The previous model (CASIA SS-1000, Tomey Corporation, Japan) supported scan depth of only 6 mm. This review summarizes the results of research on the clinical use of CASIA2 tomograph.
13 November 2020 in Ophthalmology in Russia
Фемтолазерная факоэмульсификация перезрелой катаракты
23 April 2024 in Russian Annals of Ophthalmology
Intravitreal injection (IVI) of anti-angiogenic drugs is one of the most common therapeutic procedures in ophthalmology. In recent years, a new non-contact study method has been developed — anterior segment optical coherence tomography (AS-OCT), which allows the formation of three-dimensional images of the lens and provides more detailed information about its structure and morphology. PURPOSE This study uses optical coherence tomography method to analyze the risks of developing changes in the posterior lens capsule in patients after IVI of an anti-angiogenic drug. MATERIAL AND METHODS The study involved 100 people (14 men and 86 women) with a natural lens and neovascular age-related macular degeneration (nAMD). The average age was 70.57±7.98 years. During the study (12 months), all patients underwent IVI of an anti-angiogenic drug aflibercept in the treat-and-extend (T&E) mode. All subjects were divided into 2 groups: with a total number of IVI less than 10 — group 1 (50 patients), and more than 10 IVI — group 2 (50 patients, of which 49 were included in the study). All patients underwent OCT using the Optopol REVO NX device (Poland) with the Anterior B-scan Wide protocol before inclusion in the study, as well as after 3, 6 and 12 months. RESULTS It was found that the risk of developing a posterior lens capsule rupture, visualized using OCT, depends on the total number of IVI (correlation coefficient 0.473 p=0.001): the more IVI, the higher the probability that damage to the posterior capsule will occur after the next IVI, and after the 15th injection the risk of developing damage to the posterior capsule increases sharply. CONCLUSION The astudy analyzed the risk factors for the development of posterior lens capsule damage that can be detected using OCT, and presented three risk groups for the development of rupture (or damage) of the posterior lens capsule depending on the number of intravitreal injections performed.
28 June 2023 in Russian Annals of Ophthalmology
Modern approach to refractive laser surgery features three main types of lamellar surgery. Two of them are types of open laser keratomileusis (LASIK and femtosecond laser-assisted LASIK), and the third — closed (SMILE). All of these techniques allow achieving good clinical outcomes but differ in possible complications. This article reviews the complications of femto-LASIK and specifically the post-operative cavitation injuries, describes the mechanism of their occurrence, variants of their course, and presents the prevention measures.